Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase

Atherosclerosis. 2011 May;216(1):161-5. doi: 10.1016/j.atherosclerosis.2011.01.025. Epub 2011 Jan 21.

Abstract

Introduction: Familial lecithin:cholesterol acyltransferase (LCAT) deficiency (FLD) is a rare recessive disorder of cholesterol metabolism characterized by the absence of high density lipoprotein (HDL) and the triad of corneal opacification, hemolytic anemia and glomerulopathy.

Patients: We here report on FLD in three siblings of a kindred of Moroccan descent with HDL deficiency. In all cases (17, 12 and 3 years of age) corneal opacification and proteinuria were observed. In the 17-year-old female proband, anemia with target cells was observed.

Results: Homozygosity for a mutation in LCAT resulted in the exchange of cysteine to tyrosine at position 337, disrupting the second disulfide bond in LCAT. LCAT protein and activity were undetectable in the patients' plasma and in media of COS7 cells transfected with an expression vector with mutant LCAT cDNA. Upon treatment with an ACE inhibitor and a thiazide diuretic, proteinuria in the proband decreased from 6g to 2g/24h.

Conclusion: This is the first report that FLD can cause nephropathy at a very early age.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anemia, Hemolytic / enzymology
  • Anemia, Hemolytic / genetics
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • COS Cells
  • Child
  • Child, Preschool
  • Chlorocebus aethiops
  • Cholesterol, HDL / blood
  • Corneal Opacity / enzymology
  • Corneal Opacity / genetics
  • Cysteine
  • Disulfides / chemistry*
  • Diuretics / therapeutic use
  • Female
  • Genetic Predisposition to Disease
  • Homozygote
  • Humans
  • Lecithin Cholesterol Acyltransferase Deficiency / blood
  • Lecithin Cholesterol Acyltransferase Deficiency / complications
  • Lecithin Cholesterol Acyltransferase Deficiency / enzymology
  • Lecithin Cholesterol Acyltransferase Deficiency / genetics*
  • Male
  • Mutation*
  • Phosphatidylcholine-Sterol O-Acyltransferase / chemistry
  • Phosphatidylcholine-Sterol O-Acyltransferase / genetics*
  • Phosphatidylcholine-Sterol O-Acyltransferase / metabolism
  • Proteinuria / drug therapy
  • Proteinuria / enzymology
  • Proteinuria / genetics*
  • Transfection
  • Treatment Outcome
  • Tyrosine

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Cholesterol, HDL
  • Disulfides
  • Diuretics
  • Tyrosine
  • Phosphatidylcholine-Sterol O-Acyltransferase
  • Cysteine